SBC Medical Announces Research Presentations at International Medical Conference "ASLS Tokyo 2026" Held in June 2026
Six Doctors from Shonan Beauty Clinic, Shonan Beauty Dermatology, and NEO Skin Clinic Take the Stage to Share the Latest Clinical Insights with the World.
IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that six doctors from Shonan Beauty Clinic, Shonan Beauty Dermatology, and NEO Skin Clinic presented their research findings at the academic conference "ASLS Tokyo 2026" held on Sunday, June 28, 2026.
ASLS (Aesthetic Surgery & Laser Society) is an international medical conference originating from South Korea that brings together experts in a wide range of fields in aesthetic healthcare, including aesthetic dermatology and aesthetic surgery, to share cutting-edge clinical insights and techniques.
At "ASLS Tokyo 2026" held on Sunday, June 28, 2026, six doctors took the stage: Dr. Ami Kim, Dr. Shoko Takahashi, Dr. Hidetaka Kakuta, and Dr. Joji Matsubara from Shonan Beauty Clinic Shinjuku Main Branch; Dr. Atsushi Hayashi, Director of Shonan Beauty Dermatology Gotanda Branch; and Dr. Soichiro Morikawa, Director of NEO Skin Clinic Ginza. They presented their latest findings based on their clinical experience and research in their respective fields of expertise, engaging in active exchanges of opinions with domestic and international participants on new treatment approaches and clinical implications in the field of aesthetic healthcare.
As technological innovation continues to accelerate in the field of aesthetic healthcare, the importance of knowledge sharing and academic collaboration, beyond the clinical setting alone, has grown considerably. Meeting the increasingly diverse needs of customers requires not only the adoption of advanced techniques, but also broad perspectives and flexible thinking. SBC Medical remains committed to advancing cutting-edge initiatives through academic presentations and research collaborations, and to upholding the safety, transparency, and enduring value of aesthetic healthcare.
Overview of "ASLS Tokyo 2026"
Venue: Main Banquet Hall "Hiten" B1F, Grand Prince Hotel Shin Takanawa Dates: Sunday, June 28, 2026 Official Website: https://asls-tokyo.jp/
Presentation Titles (in alphabetical order of speakers' last names)
Dr. Atsushi Hayashi (Director, Shonan Beauty Dermatology Gotanda Branch) Perioral Rejuvenation with Hyaluronic Acid and Botox
Dr. Hidetaka Kakuta (Shonan Beauty Clinic Shinjuku Main Branch) New
Approaches in Sagging Treatment and Skin Rejuvenation
Dr. Ami Kim (Shonan Beauty Clinic Shinjuku Main Branch) Utility of Non
Incisional Ptosis Correction: A Minimally Invasive Approach Based on Indication Selection and Reproducibility
Dr. Joji Matsubara (Shonan Beauty Clinic Shinjuku Main Branch)
・Customized Under-Eye Rejuvenation Tailored to Each Customer
・PDLLA for Improving Skin Quality and Pigmentation: An Evidence-Based Clinical Approach
Dr. Soichiro Morikawa (Director, NEO Skin Clinic Ginza)
・Skin Rejuvenation with Needle-Free Jet Injection of PDLLA: A Case Series
・Polynucleotides in the Era of Skin Quality Improvement: Expanding Indications and Treatment Strategies with DOT™-PN Injections
Dr. Shoko Takahashi (Shonan Beauty Clinic Shinjuku Main Branch) Facial Contouring Approach Using a Combination of Facial Liposuction and Thread Lifting
About SBC Medical Group Holdings Incorporated SBC Medical Group Holdings Incorporated is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose "Contributing to the well-being of people around the world through medical innovation," SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com For more insights and updates from SBC Medical, follow us on Linkedin.
Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," "targets" or "hopes" or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.
Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp